Thursday, September 17, 2026RSS
Peptide.Wire

The daily wire on therapeutic peptides. Regulatory, research, compounding and the incretin race, condensed.

Marketsnovo nordisknvorebrandglp-1

Novo Nordisk stock posts worst week since February amid rebrand

Shares slid as the Danish drugmaker shortened its corporate name to 'Novo' during another difficult year for the company.

TR
By Tom Reyes · Markets Editor
Sep 16 15:38 ETSource: Stocktwits

The wire

  1. 01Novo Nordisk shares logged their worst weekly decline since February as the company rebranded to 'Novo'.
  2. 02The selloff underscores investor doubts about Novo's obesity franchise momentum.
  3. 03Whether the rebrand accompanies strategic changes is not yet clear.

From the source

NVO Stock Logs Worst Week Since February As Novo Nordisk Rebrands To ‘Novo’ Amid Another Gloomy Year

Read at news.google.com